SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 24, 2004
iCAD, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-9341 02-0377419
---------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
4 Townsend West, Suite 17, Nashua, NH 03063
---------------------------------------------------
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code (603) 882-5200
--------------------------------------------------------------------------------
(Former name or former address, if changed since the last report)
Item 9. Regulation FD Disclosure
Pursuant to Regulation FD, the Registrant hereby furnishes materials with
respect to its Business Plan, Strategy and Recent Combined Performance that it
intends to distribute to organizations making purchases of computer aided
detection of breast cancer products, prospective investors and others. A copy of
such materials is attached as Exhibit 99 to this Report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
iCAD, INC.
By /s/ W. Scott Parr
-----------------------------------
W. Scott Parr,
President & Chief Executive Officer
Dated: February 24, 2004
2.